Literature DB >> 3138519

Neurologic complications of immunosuppressive agents.

R W Walker1, J A Brochstein.   

Abstract

The immunosuppressive agents that are an integral part of organ transplantation serve to protect grafts from rejection as well as to prevent or treat GVHD. They include CsA, corticosteroids, OKT3 monoclonal antibody, HDARA-C, azathioprine, and ATG. Of these, all but azathioprine and ATG have direct neurologic complications that are due to the drugs themselves and not just excessive immune suppression. With increasing success in solid organ and bone marrow transplantation and increasing patient survival, one can expect to see more patients who suffer neurologic toxicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3138519

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

1.  Delusions and cyclosporine toxicity.

Authors:  J V Bowler; R C Peatfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury.

Authors:  Patrick G Sullivan; Andrea H Sebastian; Edward D Hall
Journal:  J Neurotrauma       Date:  2011-02-02       Impact factor: 5.269

3.  Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor.

Authors:  Aiko Kida; Kazuteru Ohashi; Takeshi Kobayashii; Miwa Sakai; Takuya Yamashita; Hideki Akiyama; Shuji Kishida; Hisashi Sakamaki
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

4.  The effects of cyclosporin-A on axonal conduction deficits following traumatic brain injury in adult rats.

Authors:  Beverly S Colley; Linda L Phillips; Thomas M Reeves
Journal:  Exp Neurol       Date:  2010-04-01       Impact factor: 5.330

5.  Synaptic Mitochondria Sustain More Damage than Non-Synaptic Mitochondria after Traumatic Brain Injury and Are Protected by Cyclosporine A.

Authors:  Jacqueline R Kulbe; Rachel L Hill; Indrapal N Singh; Juan A Wang; Edward D Hall
Journal:  J Neurotrauma       Date:  2016-10-13       Impact factor: 5.269

6.  Saccadic latency in hepatic encephalopathy: a pilot study.

Authors:  Florian Krismer; Jonathan C P Roos; Melanie Schranz; Ivo W Graziadei; Sergei Mechtcheriakov; Wolfgang Vogel; R H S Carpenter; Heinz Zoller
Journal:  Metab Brain Dis       Date:  2010-09-18       Impact factor: 3.584

Review 7.  Acute leucoencephalopathy during cyclosporin A therapy in a patient with nephrotic syndrome.

Authors:  C Shimizu; S Kimura; Y Yoshida; A Nezu; K Saitoh; H Osaka; Y Aihara; Y Nagasaka
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

Review 8.  Neuropathologic findings after liver transplantation.

Authors:  J A Ferreiro; M A Robert; J Townsend; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Diagnosis and treatment of status epilepticus in a pediatric renal recipient.

Authors:  Gao Hongjun; Luo Xiangdong; Liang Taisheng; Lu Shangguang; Liang Fangfang; Dong Yu; Tan Zhen; Wu Zhen
Journal:  Case Rep Transplant       Date:  2012-01-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.